Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Klein

Showing results (1021-1030 of 1,374) with videos related to

Pageof 138
Sort By:
JAMA Internal Medicine|December 9, 2014
Liver fibrosis progression in hepatitis C virus infection after seroconversionAdeel A Butt, Peng Yan, Vincent Lo Re, et al.
AIDS (London, England)|March 11, 2010
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruptionGregory J Dore, Vicente Soriano, Jürgen Rockstroh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 2, 2015
Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort StudyJim Young, Yongling Xiao, Erica E M Moodie, et al.
Molecular Cancer Therapeutics|August 8, 2006
AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolinAllicia C Girvan, Yun Teng, Lavona K Casson, et al.
HIV Clinical Trials|May 15, 2015
Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort studyMan Wah Yeung, Jim Young, Erica Moodie, et al.
Neurobiology of Aging|June 14, 2005
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysisRukhsana Sultana, Debra Boyd-Kimball, H Fai Poon, et al.
Neurobiology of Aging|July 6, 2005
Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesisH Fai Poon, Holly M Shepherd, Tanea T Reed, et al.
Blood|April 18, 1998
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory GroupP R Greipp, T Leong, J M Bennett, et al.
American Journal of Ophthalmology|December 10, 2002
Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trialThomas A Ciulla, Ronald P Danis, Susan B Klein, et al.
Journal of Viral Hepatitis|April 18, 2023
A population-based study of reported hepatitis C diagnoses from 1998 to 2018 in immigrants and nonimmigrants in Quebec, CanadaAna Maria Passos-Castilho, Donald G Murphy, Karine Blouin, et al.
Pageof 138

Showing results (1021-1030 of 1,374) with videos related to

Sort By:
Pageof 138
JAMA Internal Medicine|December 9, 2014
Liver fibrosis progression in hepatitis C virus infection after seroconversionAdeel A Butt, Peng Yan, Vincent Lo Re, et al.
AIDS (London, England)|March 11, 2010
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruptionGregory J Dore, Vicente Soriano, Jürgen Rockstroh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 2, 2015
Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort StudyJim Young, Yongling Xiao, Erica E M Moodie, et al.
Molecular Cancer Therapeutics|August 8, 2006
AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolinAllicia C Girvan, Yun Teng, Lavona K Casson, et al.
HIV Clinical Trials|May 15, 2015
Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort studyMan Wah Yeung, Jim Young, Erica Moodie, et al.
Neurobiology of Aging|June 14, 2005
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysisRukhsana Sultana, Debra Boyd-Kimball, H Fai Poon, et al.
Neurobiology of Aging|July 6, 2005
Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesisH Fai Poon, Holly M Shepherd, Tanea T Reed, et al.
Blood|April 18, 1998
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory GroupP R Greipp, T Leong, J M Bennett, et al.
American Journal of Ophthalmology|December 10, 2002
Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trialThomas A Ciulla, Ronald P Danis, Susan B Klein, et al.
Journal of Viral Hepatitis|April 18, 2023
A population-based study of reported hepatitis C diagnoses from 1998 to 2018 in immigrants and nonimmigrants in Quebec, CanadaAna Maria Passos-Castilho, Donald G Murphy, Karine Blouin, et al.
Pageof 138